KAKEN PHARMACEUTICAL CO.,LTD.

4521

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-07FY2027 Q1

Revenue

881.6100M JPY

YoY -6.9%

Operating Income

109100M JPY

YoY +77771.4%

Net Income

103.1100M JPY

YoY -17.3%

EPS

222.9JPY

YoY +3025.7%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

940.4億円

703億円

465.7億円

228.3億円

-9億円

Rev: 760.3億円Op: 170.6億円NI: 95.5億円

Rev: 729.8億円Op: 80億円NI: 54.4億円

Rev: 720.4億円Op: 95.1億円NI: 80.3億円

Rev: 940.4億円Op: 210.3億円NI: 139.4億円

Rev: 768.7億円Op: -9億円NI: 21.4億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income129.8%

Revenue Progress301.500M

Revenue Forecast89900M

Net Income Progress84.400M

Net Income Forecast6500M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan